266 related articles for article (PubMed ID: 8421081)
1. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
Laue L; Jones J; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
[TBL] [Abstract][Full Text] [Related]
2. Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.
Leschek EW; Jones J; Barnes KM; Hill SC; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):175-8. PubMed ID: 9920079
[TBL] [Abstract][Full Text] [Related]
3. Treatment of familial male precocious puberty with spironolactone and testolactone.
Laue L; Kenigsberg D; Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
N Engl J Med; 1989 Feb; 320(8):496-502. PubMed ID: 2492636
[TBL] [Abstract][Full Text] [Related]
4. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
5. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
6. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
7. Testolactone treatment of precocious puberty in McCune-Albright syndrome.
Foster CM; Pescovitz OH; Comite F; Feuillan P; Shawker T; Loriaux DL; Cutler GB
Acta Endocrinol (Copenh); 1985 Jun; 109(2):254-7. PubMed ID: 3925675
[TBL] [Abstract][Full Text] [Related]
8. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
[TBL] [Abstract][Full Text] [Related]
9. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
10. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
[TBL] [Abstract][Full Text] [Related]
12. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
[TBL] [Abstract][Full Text] [Related]
13. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
14. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
15. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
[TBL] [Abstract][Full Text] [Related]
16. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
[TBL] [Abstract][Full Text] [Related]
17. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
18. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
Rosenthal SM; Grumbach MM; Kaplan SL
J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
